Can The Cure For Cancer Lie In Vaccines?

Combatting these killers are companies like Anixa Biosciences (NASDAQ:ANIX), a biotech company leading the fight against cancer and infectious disease through therapies and vaccines. The company currently reports having four solutions in development, including:

Anixa tells Benzinga it has made several advancements in its projects in 2022. 

Bites By Numbers

According to data given to Benzinga, Anixa Biosciences: 

Anixa Biosciences recently announced clinical trials for its CAR-T ovarian cancer treatment in addition to the breast cancer vaccine trial the Company is already engaged in.

Click here to keep track of Anixa’s story

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Featured photo by Julia Koblitz on Unsplash

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.